Kenvue Inc. is a consumer health company that markets over-the-counter medicines, skin care, hair care, and personal care products. The company operates through three business segments: Self Care, which includes cough, cold, allergy, pain, and digestive health products; Skin Health and Beauty, covering face, body, hair, and sun care; and Essential Health, comprising oral care, baby care, wound care, and menstrual health products. Kenvue serves consumers in North America, Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company was incorporated in 2022 and completed its separation from Johnson & Johnson in 2023. In November 2025, Kenvue entered into a merger agreement with Kimberly-Clark Corporation to form a combined health and wellness company.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Household & Personal Products Homepage kenvue.com
Sector Consumer Defensive IR page investors.kenvue.com/overview/default.aspx
Tags
consumer health, over-the-counter medicines, skin care, hair care, oral care, baby care, wound care, menstrual health, pain relief, allergy relief, smoking cessation, digital health, Aveeno, BAND-AID Brand, Johnson's, Listerine, Neutrogena, Nicorette, Tylenol, Zyrtec, Benadryl, Calpol, Motrin, Rhinocort, Zarbee's, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, OGX, Rogaine, Carefree, Desitin, o.b. tampons, Stayfree, Versalie
Press page —

Metrics

Valuation  
Market cap $ 33.923B
Market cap (USD) $ 33.923B
P/E 20.30
PEG —
P/BV 3.34
P/S 2.18
P/OCF 12.42
P/FCF 14.51
Dividend yield 0.34%
Turnover / mcap —
Returns  
ROE 14.4%
ROI 8.0%
ROIC 9.6%
Profit margin 9.7%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) -10.7%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 71.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 20
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 15.124B 15.455B 15.444B 14.95B 15.054B
Net profit 1.47B 1.03B 1.664B 2.064B 2.078B
Free cash flow 1.722B 1.335B 2.699B 2.15B 39M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 17.25 21.35 21.53 — —
Price performance 12m -0.19 -0.01 -0 — —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 2.12B 2.07B 2.17B 2.38B
↳ YoY growth -2.3% +4.4% +10.0%
Borrowings, current (USD) — — 0.00 600M 1.55B 1.45B
Lease liabilities (USD) — — 116M 141M 112M 150M
Cash and deposits (USD) 618M 740M 1.23B 1.38B 1.07B 1.06B
Intangible assets (USD) — — 9.85B 9.62B 8.47B 8.69B
Right-of-use assets (USD) — — 110M 139M 111M 151M
Net debt (borrowings + leases - cash) (USD) — — -1.12B -641M 592M 538M
Cash flow detail
Operating cash flow (USD) — 334M 2.53B 3.17B 1.77B 2.2B
Purchases of property, plant and equipment (USD) — -295M -375M -469M -434M -475M
Change in receivables (cash effect) (USD) — -303M -142M 44M -218M -112M
Change in inventories (cash effect) (USD) — -77M -582M 349M 182M -12M
Change in payables (cash effect) (USD) — 330M 52M 390M -536M 41M
Dividends paid (cash effect) (USD) — 0.00 0.00 -766M -1.55B -1.58B
Share buybacks (cash effect) (USD) — — 0.00 -7M -235M -197M
Interest paid (cash effect) (USD) — 0.00 0.00 -224M -439M -440M
Income taxes paid (cash effect) (USD) — -363M -316M -699M -810M -595M
Share-based compensation (USD) — 141M 137M 188M 254M 136M
Operating cash flow before change in receivables (USD) — 637M 2.67B 3.12B 1.99B 2.31B
Free cash flow (OCF - PPE - intangibles) (USD) — 39M 2.15B 2.7B 1.34B 1.72B
Income detail
Research and development expense (USD) — 355M 375M 399M 408M 382M
Total comprehensive income (USD) — 1.18B 1.09B 1.82B 261M 2.66B
Comprehensive income to owners (USD) — 1.18B 1.09B 1.82B 261M 2.66B
Provision for credit losses (USD) — 4M 9M 4M 6M 11M
Credit cost ratio (credit losses / average receivables) (%) — — — 0.2% 0.3% 0.5%
Reported Mar 1, 2024 Mar 1, 2024 Feb 24, 2025 Feb 24, 2025 Feb 24, 2025 Feb 20, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

On November 4, 2026 (the “Settlement Date”), Kimberly-Clark Corporation (“Kimberly-Clark”) completed the previously announced offers to exchange (each an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding Kenvue Notes (as defined below) issued by Kenvue LLC (as successor in interest to Kenvue Inc.) (“Kenvue”) for up to $7,000,000,000 aggregate principal amount of new notes issued by Kimberly-Clark and cash and related consent solicitations (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”) made by Kimberly-Clark on behalf of Kenvue to adopt certain amendments (the “Amendments”) to the Kenvue Indenture (as defined below) governing the Kenvue Notes. Pursuant to the Exchange Offers and Consent Solicitations, the aggregate principal amounts of the Kenvue Notes set forth below were validly tendered and accepted for exchange. Such accepted Kenvue Notes have been retired and canceled and will not be reissued. Following such cancellation, the aggregate principal amounts of the Kenvue Notes set forth below remain outstanding.

The information set forth in the Introductory Note of this Current Report on Form 8-K (this “Current Report”) is incorporated by reference into this Item 1.02.

Concurrently with the closing of the First Merger, the Company repaid in full all fees, expenses and other obligations outstanding under, and terminated all commitments in effect under, the Credit Agreement, dated as of March 6, 2023 (the “Credit Agreement”), among the Company, the subsidiaries of the Company party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Credit Agreement provided for a five-year senior unsecured revolving credit facility in an aggregate principal amount of $4.0 billion to be made available in U.S. dollars and Euros. As of the closing of the First Merger, there were no borrowings outstanding under the Credit Agreement.

Effective as of the closing of the Mergers, the Company terminated the Company’s Long-Term Incentive Plan and the Company’s Deferred Fee Plan for Directors.

Completion of Acquisition or Disposition of Assets

The information set forth in the Introductory Note of this Current Report is incorporated by reference into this Item 2.01.

Kenvue Reports Third Quarter 2026 Results Bull 3 Bear 0 Results

•Delivered Fourth Consecutive Quarter of Net and Organic Sales1 Growth

•Net Sales Increased 3.2%; Organic Sales Increased 2.9%

•Diluted EPS Increased 5% to $0.22; Adjusted Diluted EPS1 Increased 4% to $0.29

SUMMIT, N.J. October 30, 2026 – Kenvue Inc. (NYSE: KVUE) today announced financial results for the fiscal third quarter ended September 27, 2026.

“We are pleased to have delivered our fourth consecutive quarter of net and organic sales growth, with strong performance in Self Care and Essential Health, along with margin expansion and strong cash generation,” said Kirk Perry, Chief Executive Officer. “Our results reflect continued momentum from disciplined execution, ongoing productivity initiatives, and investment in our brands and innovation. We are strongly on track to deliver our business transformation that we began last year.

Prompts

Kenvue Inc. (ticker KVUE), listed in United States.

Company History

Date Change Detail
Sep 28, 2022 Renamed JNTL, Inc. → KENVUE INC.

ETFs Holding Kenvue Inc.

ETF Weight in ETF Shares Market value As of
AQEC 1.69% 507,930 $ 9.707M Jun 30, 2026
MMID 1.25% 24,073 $ 454.498K Aug 31, 2026
BUSA 1.01% 158,457 $ 3.028M Jun 30, 2026
CAPE 0.60% 75,376 $ 1.44M Jun 30, 2026
FFLC 0.55% 342,066 $ 6.581M Jul 31, 2026
BTAL 0.45% 67,298 $ 1.286M Jun 30, 2026
GMOV 0.42% 23,793 $ 449.212K Aug 31, 2026
FEMV 0.23% 644 $ 12.307K Jun 30, 2026
FLSP 0.19% 91,686 $ 1.752M Jun 30, 2026
RAA 0.17% 52,748 $ 1.008M Jun 30, 2026
FMDE 0.17% 649,379 $ 12.41M Jun 30, 2026
ACIO 0.11% 130,101 $ 2.503M Jul 31, 2026
ADME 0.11% 16,048 $ 308.764K Jul 31, 2026
VSLU 0.06% 18,106 $ 346.006K Jun 30, 2026
FELV 0.06% 105,673 $ 2.019M Jun 30, 2026
FEAC 0.06% 808 $ 15.441K Jun 30, 2026
VOXP 0.05% 162 $ 3,116.88 Jul 31, 2026
NTSX 0.05% 32,781 $ 626.445K Jun 30, 2026
HCMT 0.05% 13,362 $ 257.085K Jul 31, 2026
NTSD 0.04% 836 $ 15.976K Jun 30, 2026
GDE 0.04% 11,377 $ 214.798K Aug 31, 2026
MSLC 0.03% 72,706 $ 1.373M Aug 31, 2026
EBI 0.03% 10,298 $ 194.426K Aug 31, 2026
APUE 0.00% 1 $ 18.88 Aug 31, 2026
GEW 0.00% 105 $ 1,982.40 Aug 31, 2026